Department of Clinical Pharmacology, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Japan.
Department of Dermatology, Keio University Graduate School of Medicine, Tokyo, Japan.
J Dermatol. 2021 Aug;48(8):e353-e367. doi: 10.1111/1346-8138.15850. Epub 2021 Jun 13.
Palmoplantar keratoderma (PPK) is a collective term for keratinizing disorders in which the main clinical symptom is hyperkeratosis on the palms and soles. To establish the first Japanese guidelines approved by the Japanese Dermatological Association for the management of PPKs, the Committee for the Management of PPKs was founded as part of the Study Group for Rare Intractable Diseases. These guidelines aim to provide current information for the management of PPKs in Japan. Based on evidence, they summarize the clinical manifestations, pathophysiologies, diagnostic criteria, disease severity determination criteria, treatment, and treatment recommendations. Because of the rarity of PPKs, there are only few clinical studies with a high degree of evidence. Therefore, several parts of these guidelines were established based on the opinions of the committee. To further optimize the guidelines, periodic revision in line with new evidence is necessary.
掌跖角化病(PPK)是一组角化障碍性疾病的统称,其主要临床症状是手掌和足底的过度角化。为了制定日本皮肤科协会批准的首个日本 PPK 管理指南,作为罕见疑难病研究组的一部分,成立了 PPK 管理委员会。这些指南旨在为日本 PPK 的管理提供当前信息。它们基于证据,总结了 PPK 的临床表现、病理生理学、诊断标准、疾病严重程度确定标准、治疗和治疗建议。由于 PPK 较为罕见,因此仅有少数具有高度证据的临床研究。因此,这些指南的几个部分是基于委员会的意见制定的。为了进一步优化指南,有必要根据新证据定期修订。